Who
Stephen Michael Rothenberg
Director
Company insider
Files Form 4 as: Director, Tyra Biosciences.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 7 May 2024
- Last trade
- 28 May 2026
- Last filed
- 1 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 1 Jun 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,160 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,160 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,200 at $0.00 | filing |
| 7 May 2024filed 9 May 2024 | TYRA Tyra Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.